These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Novel agents to manage dyslipidemias and impact atherosclerosis. Nachimuthu S; Raggi P Cardiovasc Hematol Disord Drug Targets; 2006 Sep; 6(3):209-17. PubMed ID: 17017903 [TBL] [Abstract][Full Text] [Related]
9. The ebbs and flows in the development of cholesterol-lowering drugs: prospects for the future. Hajhosseiny R; Sabir I; Khavandi K; Wierzbicki AS Clin Pharmacol Ther; 2014 Jul; 96(1):64-73. PubMed ID: 24699033 [TBL] [Abstract][Full Text] [Related]
10. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Evans M; Roberts A; Davies S; Rees A Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326 [TBL] [Abstract][Full Text] [Related]
11. [Molecular pharmacology and medicinal chemistry of fibrate]. Steinhilber D; Schubert-Zsilavecz M Pharm Unserer Zeit; 2007; 36(2):108-12. PubMed ID: 17424995 [No Abstract] [Full Text] [Related]
12. Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor. Junquero D; Oms P; Carilla-Durand E; Autin J; Tarayre J; Degryse A; Patoiseau J; Colpaert FC; Delhon A Biochem Pharmacol; 2001 Jan; 61(1):97-108. PubMed ID: 11137714 [TBL] [Abstract][Full Text] [Related]
13. Intestinal sterol transporters and cholesterol absorption inhibition. Davis HR; Tershakovec AM; Tomassini JE; Musliner T Curr Opin Lipidol; 2011 Dec; 22(6):467-78. PubMed ID: 22101558 [TBL] [Abstract][Full Text] [Related]
14. [New results in the management of hypercholesterolemia]. Sármán B Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867 [TBL] [Abstract][Full Text] [Related]
17. Current drug targets for antihyperlipidemic therapy. Jain KS; Kulkarni RR; Jain DP Mini Rev Med Chem; 2010 Mar; 10(3):232-62. PubMed ID: 20105132 [TBL] [Abstract][Full Text] [Related]
18. The treatment of dyslipidemia--what's left in the pipeline? Rau O; Zettl H; Popescu L; Steinhilber D; Schubert-Zsilavecz M ChemMedChem; 2008 Feb; 3(2):206-21. PubMed ID: 17963209 [TBL] [Abstract][Full Text] [Related]
19. Emerging strategies for the treatment of atherosclerosis as seen from the patent literature. Suckling KE Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):660-2. PubMed ID: 8224485 [No Abstract] [Full Text] [Related]
20. Reverse cholesterol transport in type 2 diabetes mellitus. Tan KC Diabetes Obes Metab; 2009 Jun; 11(6):534-43. PubMed ID: 19175378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]